PRESIDENT HAS SERVED AS A REVIEWER FOR THE ZRG1 BST-H (50) PAR-16-390 ‘NIBIB Trailblazer Award for New and Early Stage Investigators’ (R21) STUDY SECTION FOR THE NIH

PDX Pharma’s President has served as a reviewer for the ZRG1 BST-H (50) PAR-16-390 ‘NIBIB Trailblazer Award for New and Early Stage Investigators’ (R21) Study Section for the National Institute of Health (NIH) held on June 28, 2017.

pdx news

  • Mr. Bejan has been accepted into Oregon Health and Science University’s PhD program as an ARCS Scholar

    4/29/2019
    read more

  • Dr. Ngamcherdtrakul presents at the 2nd Annual Formulation & Drug Delivery USA Congress.

    3/20/2019
    read more

  • Data on Functionalized Mesoporous Silica for Removing Heavy Metals Accepted for Publication in Scientific Reports (IF = 4.122)

    1/29/2019
    read more

Copyright © 2017 PDX Pharmaceuticals, LLC. All rights reserved